REBECCA SAYER: Open Payments
NPI 1750604625 · NEW IBERIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 5 companies in 2025. Trend: 2023 $1,397 · 2024 $1,224 · 2025 $161
Food & beverage: $147Education: $14
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $74 |
| GENZYME CORPORATION | 1 | $31 |
| Amgen Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CREON, DUPIXENT, TEZSPIRE, EOHILIA.
Industry payments across LA — which companies pay providers there.
